Alan Crane, Director, Ten Percent Owner at Daré Bioscience, holds 0.00 shares in Pandion Therapeutics (Ticker: PAND), holds 30.00K shares in T2 Biosystems (Ticker: TTOO), holds 4.77M shares in Daré Bioscience (Ticker: DARE).

See the Hottest Stocks Based on Insider Trading >

Alan Crane
Daré Bioscience (DARE)
Director, Ten Percent Owner

Ranked #62,536 out of 98,743 Corporate Insiders

Profitable Transactions

0 out of 3 Profitable Transactions

Average Return

-10.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

93.98%

DARE

6.02%

TTOO

A breakdown of Alan Crane's holdings

See the Top Stocks by Insiders

Insider Roles

Daré Bioscience
(DARE)

Director, Ten Percent Owner

T2 Biosystems
(TTOO)

Director

Roles that Alan Crane holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Daré Bioscience
(DARE)

Rating:Informative Buy

Date:Apr 15, 2014 - Apr 15, 2015

Return:-1.80%

The most profitable trade made by Alan Crane

See the Latest Stocks Traded by Insiders

Alan Crane's Trading History

DARE

Daré Bioscience

Apr 15, 2014

Director, Ten Percent Owner

Uninformative Buy

4.88M

$1.49M

PAND

Pandion Therapeutics

Apr 01, 2021

―

Uninformative Sell

217.31M

$0.00

MNTA

Momenta Pharma

Apr 16, 2010

―

Informative Buy

146.96K

$32.21M

TTOO

T2 Biosystems

Aug 14, 2014

Director

Informative Buy

330.00K

$95.70K

List of latest transactions for each holding click on a transaction to see Alan Crane's performance on stock

See All Insider Trading from Today

Alan Crane insider profile FAQ

What is the percentage of profitable transactions made by Alan Crane?

The percentage of profitable transactions made by Alan Crane is 0%.

What is the average return per transaction made by Alan Crane?

The average return per transaction made by Alan Crane is -10.10%.

What stocks does Alan Crane hold?

Alan Crane holds: DARE, PAND, MNTA, TTOO stocks.

What was Alan Crane’s latest transaction?

Alan Crane latest transaction was an Uninformative Sell of $217.31M.

What was Alan Crane's most profitable transaction?

Alan Crane’s most profitable transaction was an Informative Buy of DARE stock on April 15, 2014. The return on the trade was -1.80%.

What is Alan Crane's role in Daré Bioscience?

Alan Crane's role in Daré Bioscience is Director, Ten Percent Owner.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Alan Crane Insider Profile

Alan Crane Daré Bioscience (DARE)Director, Ten Percent Owner